)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Aprea Therapeutics
Aprea Therapeutics (APRE) investor relations material
Aprea Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary30 Apr, 2026
Executive summary
Annual meeting scheduled for June 16, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote by June 15, 2026.
Voting matters and shareholder proposals
Election of three Class I directors: Marc Duey, Richard Peters, M.D., and Bernd R. Seizinger, M.D., Ph.D.
Ratification of EisnerAmper LLP as independent registered public accounting firm for fiscal year 2026.
Approval of a reverse stock split at a ratio between one-for-three and one-for-eight, with the exact ratio and timing at the Board's discretion.
Non-binding advisory vote on executive compensation and on the frequency of future say-on-pay votes.
Approval to adjourn the meeting if additional proxies are needed for the reverse stock split proposal.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director elections and corporate actions.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Aprea Therapeutics
- Key votes include director elections, a reverse stock split, and annual say-on-pay, all Board-recommended.APRE
Proxy filing30 Apr 2026 - Registering 74M+ shares for resale, with proceeds from warrants funding clinical trials amid going concern risks.APRERegistration filing23 Apr 2026
- APR-1051 demonstrates early efficacy and safety as a selective WEE1 inhibitor in targeted cancers.APRECorporate presentation20 Apr 2026
- Key votes include director elections, a reverse stock split, and executive compensation approval.APREProxy filing20 Apr 2026
- Shelf registration filed amid auditor's going concern warning and strong scientific leadership.APRERegistration Filing17 Mar 2026
- Clinical progress and improved financials position the company for key milestones in 2026.APREQ4 202516 Mar 2026
- Promising early data for a daily WEE1 inhibitor show efficacy and safety in targeted cancer patients.APREOppenheimer 36th Annual Healthcare Life Sciences Conference26 Feb 2026
- Registering 12.6M shares for resale, with proceeds from warrants funding clinical trials amid financial risk.APRERegistration Filing20 Feb 2026
- APR-1051 demonstrates potent, selective WEE1 inhibition with a differentiated safety profile in early trials.APREStudy Update3 Feb 2026
Next Aprea Therapeutics earnings date
Q1 202620 May, 2026
Aprea Therapeutics
Next Aprea Therapeutics earnings date
Q1 202620 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage